279
Pyxis Oncology, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
187
FY23:
125
FY24:
132
FY25:
72.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.35
FY22:
24.8
FY23:
49.1
FY24:
24.7
FY25:
19.4
Total assets
Change from FY21 to FY25
millions USD
FY21:
280
FY22:
211
FY23:
174
FY24:
157
FY25:
91.5
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
18.7
FY22:
31.6
FY23:
25.8
FY24:
17.7
FY25:
21.1
(negative)
millions USD
FY21:
0
FY22:
18.9
FY23:
22.3
FY24:
18.8
FY25:
17.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
261
FY22:
161
FY23:
126
FY24:
121
FY25:
53.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
280
FY22:
211
FY23:
174
FY24:
157
FY25:
91.5
All amounts in millions USD